Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2010
Title: Innovations of Yue-Hao Wang in Protein Tyrosine Kinase Inhibition
Introduction
Yue-Hao Wang is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents targeting protein tyrosine kinases. His innovative work has the potential to impact various medical applications.
Latest Patents
Yue-Hao Wang holds a patent titled "Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents." This invention involves a bisubstrate inhibitor of Src kinases, which includes a nucleotide or N-heteroaromatic moiety linked to a peptide/phosphopeptide, peptidomimetic, or phosphopeptide mimic moiety. The moieties are connected by either a rigid or flexible linker. The nucleotide or N-heteroaromatic moiety can be ATP or its mimics, as well as various purine and pyrimidine derivatives. The phosphopeptide mimics are designed to inhibit the Src kinases SH2 domain, showcasing Wang's innovative approach to therapeutic development.
Career Highlights
Throughout his career, Yue-Hao Wang has worked with notable organizations, including the Board of Governors for Higher Education and the State of Rhode Island and Providence Plantations. His experience in these institutions has contributed to his expertise in the field of biochemistry and patent development.
Collaborations
Yue-Hao Wang has collaborated with esteemed colleagues, including Keykavous Parang and Gongqin Sun. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Yue-Hao Wang's contributions to the field of protein tyrosine kinase inhibition exemplify the importance of innovation in therapeutic development. His patent and collaborative efforts highlight the potential for advancements in medical treatments.